-
- ITO Kiyomi
- Department of Clinical Pharmacokinetics, Hoshi University
-
- TAKASAKI Ayaka
- Department of Clinical Pharmacokinetics, Hoshi University
-
- IKARASHI Nobutomo
- Department of Clinical Pharmacokinetics, Hoshi University
-
- WATANABE Junko
- TSUMURA Research Laboratories, Tsumura & Co.
-
- KANITANI Masanao
- TSUMURA Research Laboratories, Tsumura & Co.
-
- SUGIYAMA Kiyoshi
- Department of Clinical Pharmacokinetics, Hoshi University
この論文をさがす
抄録
In order to evaluate the possibility of Kampo medicines causing pharmacokinetic drug-drug interactions, the effects of 3 Kampo medicines (rikkunshito, yokukansan and boiogito) on the activities of cytochrome P450 (CYP) and P-glycoprotein (P-gp) were investigated in a mouse in vivo study using triazolam and digoxin, respectively, as probe substrates.<BR>A significant increase in the plasma triazolam concentration was observed by co-administration of ketoconazole, a Cyp3a inhibitor, whereas none of the Kampo medicines tested showed any significant effects on triazolam pharmacokinetics in mice. Similarly, plasma concentration of digoxin was significantly elevated by quinidine co-administration, while unaffected by any of the Kampo medicines investigated.<BR>These findings indicate that rikkunshito, yokukansan and boiogito are unlikely to affect the pharmacokinetics of co-administered drugs which are substrates of CYP3A and/or P-gp.
収録刊行物
-
- Journal of Traditional Medicines
-
Journal of Traditional Medicines 26 (3), 131-135, 2009
和漢医薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680210172544
-
- NII論文ID
- 130004495541
- 110007356319
-
- NII書誌ID
- AA12035198
-
- ISSN
- 18813747
- 18801447
-
- NDL書誌ID
- 10435107
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可